Catherine Mazzacco is of Sight Sciences, Inc.. Currently has a direct ownership of 41,015 shares of SGHT, which is worth approximately $291,616. The most recent transaction as insider was on Sep 11, 2025, when has been sold 37,492 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41K
0% 3M change
13.75% 12M change
Total Value Held $291,616

Catherine Mazzacco Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 11 2025
SELL
Bona fide gift
-
37,492 Reduced 47.76%
41,015 Common Stock
Jun 05 2025
BUY
Grant, award, or other acquisition
-
30,952 Added 28.28%
78,507 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
17,366 Added 26.75%
47,555 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
30,189 Added 100.0%
0 Common Stock

Also insider at

KRYS
Krystal Biotech, Inc. Healthcare
CM

Catherine Mazzacco

Pittsburgh, PA

Track Institutional and Insider Activities on SGHT

Follow Sight Sciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGHT shares.

Notify only if

Insider Trading

Get notified when an Sight Sciences, Inc. insider buys or sells SGHT shares.

Notify only if

News

Receive news related to Sight Sciences, Inc.

Track Activities on SGHT